Aether Industries Ltd
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]
- Market Cap ₹ 21,590 Cr.
- Current Price ₹ 1,627
- High / Low ₹ 1,692 / 723
- Stock P/E 116
- Book Value ₹ 1,816
- Dividend Yield 0.00 %
- ROCE 9.99 %
- ROE 7.78 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.90 times its book value
- Company has delivered good profit growth of 90.9% CAGR over last 5 years
- Company's median sales growth is 49.5% of last 10 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.49% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 24 | 109 | 201 | 302 | 450 | 590 | 651 | 596 | 7,903 | 9,402 | 981 | |
| 3 | 1 | 22 | 85 | 154 | 230 | 338 | 422 | 465 | 464 | 5,630 | 6,447 | 676 | |
| Operating Profit | -2 | -1 | 2 | 23 | 48 | 72 | 112 | 168 | 186 | 131 | 2,273 | 2,954 | 305 |
| OPM % | -252% | -194% | 10% | 21% | 24% | 24% | 25% | 28% | 29% | 22% | 29% | 31% | 31% |
| 4 | 1 | 0 | 0 | 2 | 2 | 4 | 7 | 17 | 30 | 306 | 126 | 23 | |
| Interest | 1 | 0 | 1 | 9 | 11 | 9 | 11 | 13 | 5 | 9 | 102 | 122 | 13 |
| Depreciation | 0 | 0 | 1 | 5 | 6 | 8 | 11 | 15 | 23 | 39 | 428 | 608 | 68 |
| Profit before tax | 0 | 0 | 1 | 9 | 33 | 57 | 94 | 146 | 174 | 114 | 2,049 | 2,350 | 248 |
| Tax % | 27% | 31% | 300% | 17% | 28% | 29% | 24% | 26% | 25% | 23% | 26% | 26% | |
| 0 | 0 | -1 | 8 | 23 | 40 | 71 | 109 | 130 | 88 | 1,521 | 1,736 | 182 | |
| EPS in Rs | 0.12 | 0.11 | -1.27 | 9.08 | 27.27 | 46.68 | 70.43 | 9.67 | 10.47 | 6.65 | 114.71 | 130.85 | 13.71 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 179% |
| 5 Years: | 84% |
| 3 Years: | 144% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 141% |
| 5 Years: | 91% |
| 3 Years: | 140% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| 1 Year: | 111% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 34 | 9 | 9 | 9 | 9 | 10 | 113 | 125 | 133 | 1,326 | 1,327 |
| Reserves | 0 | 0 | -1 | 7 | 30 | 70 | 164 | 274 | 1,120 | 1,936 | 20,926 | 22,766 |
| 35 | 53 | 111 | 126 | 126 | 172 | 211 | 291 | 16 | 144 | 1,371 | 3,563 | |
| 1 | -21 | 19 | 18 | 42 | 50 | 67 | 92 | 120 | 143 | 1,989 | 2,372 | |
| Total Liabilities | 45 | 65 | 137 | 159 | 207 | 300 | 453 | 770 | 1,380 | 2,356 | 25,612 | 30,028 |
| 1 | 1 | 56 | 100 | 106 | 129 | 216 | 257 | 646 | 743 | 9,885 | 13,722 | |
| CWIP | 20 | 42 | 40 | 2 | 1 | 17 | 0 | 58 | 37 | 219 | 3,396 | 4,823 |
| Investments | 8 | 0 | 0 | 0 | 0 | 0 | 22 | 17 | 1 | 0 | 1,003 | 1,003 |
| 15 | 21 | 41 | 56 | 99 | 154 | 214 | 438 | 695 | 1,393 | 11,328 | 10,481 | |
| Total Assets | 45 | 65 | 137 | 159 | 207 | 300 | 453 | 770 | 1,380 | 2,356 | 25,612 | 30,028 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3 | -6 | -9 | 6 | 23 | 18 | 23 | -5 | -7 | -2 | 1,173 | 1,463 | |
| 2 | -14 | -48 | -11 | -13 | -48 | -77 | -151 | -348 | -399 | -4,149 | -5,900 | |
| -6 | 17 | 57 | 4 | -10 | 33 | 55 | 169 | 439 | 854 | -194 | 2,109 | |
| Net Cash Flow | -8 | -3 | -1 | -0 | 0 | 2 | 2 | 12 | 84 | 453 | -3,171 | -2,329 |
| Free Cash Flow | -16 | -29 | -63 | -5 | 10 | -30 | -53 | -157 | -363 | -305 | -3,047 | -4,660 |
| CFO/OP | 157% | 994% | -400% | 26% | 60% | 43% | 39% | 17% | 14% | 12% | 76% | 65% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 4,358 | 167 | 88 | 87 | 76 | 88 | 101 | 145 | 141 | 122 | 119 |
| Inventory Days | 52 | 9,733 | 629 | 149 | 133 | 166 | 141 | 221 | 301 | 411 | 377 | 429 |
| Days Payable | 172 | 1,922 | 575 | 92 | 76 | 88 | 82 | 95 | 99 | 113 | 111 | 129 |
| Cash Conversion Cycle | -25 | 12,169 | 220 | 144 | 144 | 153 | 147 | 227 | 348 | 439 | 387 | 418 |
| Working Capital Days | -794 | 9,037 | -18 | 49 | 11 | 32 | 36 | 82 | 268 | 360 | 277 | 200 |
| ROCE % | -1% | -0% | 2% | 14% | 28% | 32% | 33% | 30% | 18% | 8% | 18% | 10% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| CRAMS Revenue as % of Total Revenue % |
|
||||||||
| R&D as % of Revenue % |
|||||||||
| R&D Expenditure INR MM |
|||||||||
| Capacity Utilization - Manufacturing Facility 2 (Site 2) % |
|||||||||
| Products in Portfolio count |
|||||||||
| Total Customers count |
|||||||||
| Capacity Utilization - Manufacturing Facility 3 (Site 3) % |
|||||||||
| Capacity Utilization - Manufacturing Facility 4 (Site 4) % |
|||||||||
| R&D Expenditure (Percentage of Turnover) % |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Business Responsibility and Sustainability Reporting (BRSR)
- Aether Industries filed FY 2025-26 BRSR and independent assurance statement with the annual report.
-
Notice Of The Annual General Meeting
- Aether Industries to hold 14th AGM on September 11, 2026; proposes reappointments of four directors.
-
Reg. 34 (1) Annual Report.
- FY26 annual report and 14th AGM notice filed; revenue rose 38% to ₹11,811 million.
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
- In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements), Regulations 2015, we herewith inform about allotment of 15,269 shares under AIL …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Aether Industries will participate in Ambit-Daiwa India Access conference in Singapore on August 17-18, 2026.
Annual reports
Concalls
-
Aug 2026Transcript PPT REC
-
Jul 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Jul 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Jan 2025Transcript PPT REC
-
Jan 2025TranscriptAI SummaryPPT
-
Oct 2024Transcript PPT REC
-
Jul 2024TranscriptPPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Jul 2023Transcript PPT
-
Jun 2023Transcript PPT
-
May 2023TranscriptAI SummaryPPT
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Jun 2022Transcript PPT
Business Segments[1] [2]
a) Contract / Exclusive Manufacturing (46% in FY26 vs 31% in FY25): [3]
The company produces products for its customers under contractual supply agreements that can be either short-term or long-term, and may be exclusive or non-exclusive in nature. It has entered into long-term take-or-pay contracts with global clients such as Baker Hughes, SEQENS, and Saudi Aramco.